Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei | Zendy

Vanaporn Wuthiekanun | Zendy; Allen C. Cheng | Zendy; Wirongrong Chierakul | Zendy; Premjit Amornchai | Zendy; Direk Limmathurotsakul | Zendy; Wipada Chaowagul | Zendy; Andrew J. H. Simpson | Zendy; Jennifer M. Short | Zendy; Gumphol Wongsuvan | Zendy; Bina Maharjan | Zendy; Nicholas J. White | Zendy; Sharon J. Peacock | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei

Author(s) -

Vanaporn Wuthiekanun,

Allen C. Cheng,

Wirongrong Chierakul,

Premjit Amornchai,

Direk Limmathurotsakul,

Wipada Chaowagul,

Andrew J. H. Simpson,

Jennifer M. Short,

Gumphol Wongsuvan,

Bina Maharjan,

Nicholas J. White,

Sharon J. Peacock

Publication year - 2005

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dki151

Subject(s) - etest , burkholderia pseudomallei , melioidosis , sulfamethoxazole , trimethoprim , microbiology and biotechnology , medicine , burkholderia , biology , antimicrobial , antibiotics , bacteria , genetics

Trimethoprim/sulfamethoxazole is commonly used to treat melioidosis. Antimicrobial susceptibility testing using the disc diffusion method is commonly used in melioidosis-endemic areas, but may overestimate resistance to trimethoprim/sulfamethoxazole.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research